HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ganglioside, disialosyl globopentaosylceramide (DSGb5), enhances the migration of renal cell carcinoma cells.

Abstract
About one third of renal cell carcinoma (RCC) patients exhibit metastasis upon initial presentation. However, the molecular basis for RCC metastasis is not fully understood. A ganglioside, disialosyl globopentaosylceramide (DSGb5), was originally isolated from RCC tissue extracts, and its expression is correlated with RCC metastatic potential. DSGb5 is synthesized by GalNAc α2,6-sialyltransferase VI (ST6GalNAcVI) and is expressed on the surface of RCC cells. Importantly, DSGb5 binds to sialic acid-binding Ig-like lectin-7 (Siglec-7) expressed on natural killer (NK) cells, thereby inhibiting NK-cell cytotoxicity. However, the role of DSGb5 in RCC progression remains obscure. To address this issue, we used ACHN cells derived from malignant pleural effusion of a patient with metastatic RCC. Using the limiting dilution method, we isolated three independent clones with different DSGb5 expression levels. Comparison of these clones indicated that the cloned cells with high DSGb5 expression levels exhibited greater migration potential, compared to the clone with low DSGb5 expression levels. In contrast, DSGb5 expression levels exerted no significant effect on cell proliferation. We then established the ACHN-derived cell lines that stably expressed siRNA against ST6GalNAcVI mRNA or control siRNA. Importantly, the ST6GalNAcVI-knockdown cells expressed low levels of DSGb5. We thus demonstrated the significantly decreased migration potential of the ST6GalNAcVI-knockdown cells with low DSGb5 expression levels, compared to the control siRNA-transfected cells expressing high DSGb5 levels, but no significant difference in the cell proliferation. Thus, DSGb5 expression may ensure the migration of RCC cells. We propose that DSGb5 expressed on RCC cells may determine their metastatic capability.
AuthorsYoshihide Kawasaki, Akihiro Ito, Narihiko Kakoi, Shuichi Shimada, Jun Itoh, Koji Mitsuzuka, Yoichi Arai
JournalThe Tohoku journal of experimental medicine (Tohoku J Exp Med) Vol. 236 Issue 1 Pg. 1-7 (05 2015) ISSN: 1349-3329 [Electronic] Japan
PMID25864532 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • DSGb5 compound
  • Globosides
  • RNA, Messenger
  • Forssman glycolipid
Topics
  • Carcinoma, Renal Cell (genetics, metabolism, pathology)
  • Cell Line, Tumor
  • Cell Movement
  • Cell Proliferation
  • Cell Separation
  • Flow Cytometry
  • Gene Expression Regulation, Neoplastic
  • Globosides (chemistry, metabolism)
  • Humans
  • Kidney Neoplasms (genetics, metabolism, pathology)
  • RNA, Messenger (genetics, metabolism)
  • Transfection

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: